Furthermore, necroptosis-associated effector proteins RIPK1, RIPK3 and MLKL, identified in the Clinical Proteomic Tumor Analysis Consortium (CPTAC) validation cohort, were all up-regulated in the tumors, in line with our transcriptomic findings (Figure 3f). This evidence concerns the gene RIPK1 and neoplasm.